Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction
- PMID: 8883280
Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction
Abstract
To assess whether plasminogen activator inhibitor 1 (PAI-1) activity is elevated in the progeny of young coronary men, 193 young subjects were recruited and divided into two groups. Group A consisted of 104 children whose fathers had suffered a myocardial infarction before the age of 55 ("cases"). Eighty-nine young subjects matched for age, sex, body mass index (BMI) and smoking habits without familial history of coronary artery disease (CAD) served as controls (group B). Children with a family history of diabetes mellitus or hypertension were excluded from both groups. We measured PAI-1 activity, tissue-type plasminogen activator (t-PA) antigen, a2-antiplasmin, fibrinogen, lipids and apolipoproteins in both groups. PAI-1 activity levels were also determined in the men who suffered a premature myocardial infarction 4 months after their discharge. PAI-1 activity levels were higher in cases compared to controls (3.13 +/- 1.9 vs 2.17 +/- 1.9 U/ml, p = 0.0014). t-PA antigen and a2-antiplasmin did not differ significantly between the two groups, while fibrinogen, total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B and lipoprotein(a) were significantly higher in group A. PAI-1 was positively correlated with triglycerides (r = 0.22, p = 0.024), apolipoprotein B (r = 0.21, p = 0.039) and fibrinogen (r = 0.22, p = 0.029) in cases and with BMI in both cases (r = 0.37, p = 0.0003) and controls (r = 0.23, p = 0.044). In stepwise multiple regression analysis, only apolipoprotein B (p = 0.008) and BMI (p = 0.0014) were significant determinants of PAI-1 activity in cases. There was also a positive correlation between PAI-1 activity levels of the affected fathers and their children (r = 0.30, p = 0.01). The present data support the hypothesis that elevated PAI-1 levels in the offspring of men with premature myocardial infarction impair their fibrinolytic capacity contributing to their familial predisposition to CAD.
Similar articles
-
Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring--the EARS study. European Atherosclerosis Research Study Group.Thromb Haemost. 1994 Apr;71(4):434-40. Thromb Haemost. 1994. PMID: 8052959
-
Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.Wien Klin Wochenschr. 2001 Feb 15;113(3-4):113-8. Wien Klin Wochenschr. 2001. PMID: 11253736
-
[Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].Sangre (Barc). 1994 Apr;39(2):111-6. Sangre (Barc). 1994. PMID: 8059288 Spanish.
-
[Correlation between juvenile myocardial infarct in parents and plasma fibrinogen levels in their offspring].Orv Hetil. 1991 Aug 25;132(34):1861-3. Orv Hetil. 1991. PMID: 1881663 Review. Hungarian.
-
Role of plasminogen activator inhibitor type 1 in the pathogenesis of coronary artery diseases.Haemostasis. 1994 Jul-Aug;24(4):243-51. doi: 10.1159/000217108. Haemostasis. 1994. PMID: 7988952 Review.
Cited by
-
Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease.J Thromb Thrombolysis. 2001 May;11(3):183-93. doi: 10.1023/a:1011955018052. J Thromb Thrombolysis. 2001. PMID: 11577256 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous